447 related articles for article (PubMed ID: 21243082)
1. Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C.
Margeridon-Thermet S; Shafer RW
Viruses; 2010 Dec; 2(12):2696-739. PubMed ID: 21243082
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B Gene Therapy Coming to Age.
Soriano V
AIDS Rev; 2018; 20(2):125-127. PubMed ID: 29938706
[TBL] [Abstract][Full Text] [Related]
3. Evolution of hepatitis C virus quasispecies during repeated treatment with the NS3/4A protease inhibitor telaprevir.
Susser S; Flinders M; Reesink HW; Zeuzem S; Lawyer G; Ghys A; Van Eygen V; Witek J; De Meyer S; Sarrazin C
Antimicrob Agents Chemother; 2015 May; 59(5):2746-55. PubMed ID: 25712364
[TBL] [Abstract][Full Text] [Related]
4. Naturally occurring antiviral drug resistance in HIV patients who are mono-infected or co-infected with HBV or HCV in China.
Deng H; Deng X; Liu Y; Xu Y; Lan Y; Gao M; Xu M; Gao H; Wu X; Liao B; Chen W; Zhao M; Hu F; Wang Z
J Med Virol; 2018 Jul; 90(7):1246-1256. PubMed ID: 29574921
[TBL] [Abstract][Full Text] [Related]
5. Management of HIV and hepatitis virus coinfection.
Mendes-Corrêa M; Núñez M
Expert Opin Pharmacother; 2010 Oct; 11(15):2497-516. PubMed ID: 20629586
[TBL] [Abstract][Full Text] [Related]
6. T-cell therapy for chronic viral hepatitis.
Bertoletti A; Tan AT; Koh S
Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
[TBL] [Abstract][Full Text] [Related]
7. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era.
Maida I; Ríos MJ; Pérez-Saleme L; Ramos B; Soriano V; Pegram PS; Mura MS; Sánchez-Margalet V; Saldívar-Cornejo I; Wilkin A; Babudieri S; Núñez M
AIDS Res Hum Retroviruses; 2008 May; 24(5):679-83. PubMed ID: 18462085
[TBL] [Abstract][Full Text] [Related]
8. Interference of replication between hepatitis B and C viruses in patients infected with HIV.
Yang RR; Gui X; Chen XY; Zhu Y
J Med Virol; 2011 Jul; 83(7):1159-64. PubMed ID: 21567419
[TBL] [Abstract][Full Text] [Related]
9. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.
Nijhuis M; van Maarseveen NM; Boucher CA
Handb Exp Pharmacol; 2009; (189):299-320. PubMed ID: 19048205
[TBL] [Abstract][Full Text] [Related]
10. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
Kumar R; Singla V; Kacharya Sk
Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
[TBL] [Abstract][Full Text] [Related]
11. Persistent Replication of HIV, Hepatitis C Virus (HCV), and HBV Results in Distinct Gene Expression Profiles by Human NK Cells.
Boeijen LL; Hou J; de Groen RA; Verbon A; Boonstra A
J Virol; 2019 May; 93(9):. PubMed ID: 30185599
[TBL] [Abstract][Full Text] [Related]
12. HIV-HBV and HIV-HCV Coinfection and Liver Cancer Development.
Hu J; Liu K; Luo J
Cancer Treat Res; 2019; 177():231-250. PubMed ID: 30523627
[TBL] [Abstract][Full Text] [Related]
13. High Rates of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human Immunodeficiency Virus Infections and Uncommon HBV Genotype/Subtype and HCV Subtype Distributions among Transgender Individuals in Surabaya, Indonesia.
Hadikusumo AA; Utsumi T; Amin M; Khairunisa SQ; Istimagfirah A; Wahyuni RM; Lusida MI; Soetjipto ; Rianto E; Juniastuti ; Hayashi Y
Jpn J Infect Dis; 2016 Nov; 69(6):493-499. PubMed ID: 27000450
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal evaluation of viral interactions in treated HIV-hepatitis B co-infected patients with additional hepatitis C and D virus.
Boyd A; Lacombe K; Miailhes P; Gozlan J; Bonnard P; Molina JM; Lascoux-Combe C; Serfaty L; Gault E; Desvarieux M; Girard PM
J Viral Hepat; 2010 Jan; 17(1):65-76. PubMed ID: 19682317
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis G virus infection in hepatitis C virus-positive patients co-infected or not with hepatitis B virus and/or human immunodeficiency virus.
Thiers V; Pol S; Persico T; Carnot F; Zylberberg H; Berthelot P; Bréchot C; Nalpas B
J Viral Hepat; 1998 Mar; 5(2):123-30. PubMed ID: 9572037
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt.
el-Sayed NM; Gomatos PJ; Rodier GR; Wierzba TF; Darwish A; Khashaba S; Arthur RR
Am J Trop Med Hyg; 1996 Aug; 55(2):179-84. PubMed ID: 8780457
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinical relevance of occult hepatitis B in the fibrosis progression and antiviral response to INF therapy in HIV-HCV-coinfected patients.
Laguno M; Larrousse M; Blanco JL; Leon A; Milinkovic A; Martínez-Rebozler M; Loncá M; Martinez E; Sanchez-Tapias JM; de Lazzari E; Gatell JM; Costa J; Mallolas J
AIDS Res Hum Retroviruses; 2008 Apr; 24(4):547-53. PubMed ID: 18393687
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection.
Shah NJ; Al-Shbool G; Blackburn M; Cook M; Belouali A; Liu SV; Madhavan S; He AR; Atkins MB; Gibney GT; Kim C
J Immunother Cancer; 2019 Dec; 7(1):353. PubMed ID: 31847881
[TBL] [Abstract][Full Text] [Related]
19. Differing prospects for the future of using gene therapy to treat infections with hepatitis B virus and hepatitis C virus.
Ely A; Arbuthnot P
Discov Med; 2015 Sep; 20(109):137-43. PubMed ID: 26463095
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
